Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 157,600 shares, a decrease of 25.4% from the June 15th total of 211,400 shares. Based on an average trading volume of 28,900 shares, the […]